TipRanks Earnings
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 168
- Sources here
- 19
- Companies here
- 5
Active search
168 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Gaxos Plans Up to 6M $0.95 Warrants in Cash Deal
Gaxos (NASDAQ: GXAI) announced agreements for the immediate cash exercise of existing warrants for approximately $3.6 million in gross proceeds. These warrants cover up to 3,007,654 shares at a reduced exercise price of $1.20 per share. In return, Gaxos will issue new unregistered warrants …
Gaxos Announces Exercise of Warrants for Approximately $3.6 Million Gross Proceeds
Gaxos.ai Inc. (NASDAQ: GXAI) announced definitive agreements for the immediate exercise of outstanding warrants, generating approximately $3.6 million in gross proceeds. The warrants, originally issued in December and September 2024 with exercise prices between $2.33 and $3.32 per share, are being exercised at a …
GSK plc (GSK) 13F filing lists 13 U.S. positions worth over $602M
GSK plc has filed a Form 13F Holdings Report, disclosing 13 U.S. securities positions with a total aggregate value of $602,220,442. This filing indicates that GSK plc is the sole institutional investment manager responsible for these holdings, with no other managers included in the …
Form 8K Xos Inc For: 13 August By Investing.com
This article from Investing.com announces that Xos Inc. filed a Form 8K on August 13th. The content is very brief, essentially just stating the filing and linking to general market data and other articles. The core information provided is the company name, the form …
Benchmark raises Axos Financial stock price target to $120 on growth
Benchmark has increased its price target for Axos Financial (NYSE:AX) shares to $120 from $115, maintaining a Buy rating due to the company's sustained above-peer growth and profitability. The new target is based on 12.8 times the firm's 2027 earnings per share estimate, reflecting …
Xos, Inc. (XOS) Reports Q2 Loss, Misses Revenue Estimates
Xos, Inc. (XOS) reported a wider-than-expected Q2 loss of $0.55 per share and missed revenue estimates with $4.74 million, compared to the Zacks Consensus Estimate of a $0.53 loss and $12.14 million in revenue. Despite recent stock outperformance, the company holds a Zacks Rank …
Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?
On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm's total Q2 turnover reached £8.4 billion, marking a 5% increase year-over-year at constant exchange rates (CER), while Core operating profit climbed …
Earnings call transcript: Xos Q2 2026 revenue miss sparks sharp after-hours drop
Xos Inc. reported a significant revenue miss in Q2 2026, with revenue of $4.7 million against an expected $12.15 million, causing its stock to drop nearly 17% in after-hours trading. Despite this, the company posted a narrower-than-expected loss of $0.55 per share and highlighted …
Dodge & Cox reports 4.3% GSK plc (GSK) stake in Schedule 13G/A
Dodge & Cox, an investment manager, has reported a 4.3% beneficial ownership stake in GSK plc, as detailed in an Amendment No. 3 to Schedule 13G filing. The filing indicates that Dodge & Cox beneficially owns 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares, …
MFS Blended Research International Equity Fund's GSK PLC(LSE:GSK) Holding History
MFS Blended Research International Equity Fund holds 1.57 million shares of GSK PLC (LSE:GSK), valued at £39.86 million, representing 0.85% of their portfolio. The fund acquired these shares at an average price of £20.07, and based on the current price of £18.57, has an …
GXAI Stock Pops As Revenue Soars And Buyback Signals Confidence
Gaxos.ai Inc. (GXAI) stock surged by over 55% due to strong Q2 2026 revenue of $2.46M, a 1,337% year-over-year increase, and positive GAAP net income. The company has strategically shifted focus from gaming to AI and health platforms, supported by a $1M share repurchase …
Axos Target Rises to $120 on Growth Above Peers
This article first appeared on GuruFocus. Axos Financial (NYSE:AX), the digital bank that runs branchless consumer and commercial lending, rose 1.67% intraday after Benchmark raised its price target to $120 from $115 and kept a Buy rating. The increase reflects a higher multiple, with …
Senior GSK plc (GSK) leaders acquire Ordinary Shares through Share Reward Plan
Several senior leaders and one closely associated person at GSK plc acquired Ordinary Shares under the company's Share Reward Plan on August 11, 2026. The acquisitions were made on the London Stock Exchange at a price of £19.3496 per share, with most individuals acquiring …
Why Is Gaxos.ai Stock Gaining Thursday?
Gaxos.ai (NASDAQ: GXAI) stock surged over 45% on Thursday, extending a rally initiated by better-than-expected second-quarter results. The company reported earnings of 2 cents per share and revenue of $2.46 million, both surpassing analyst estimates. Gaxos.ai develops AI-powered products for various markets and demonstrated …
GXAI Stock Pops As Gaxos.ai Delivers Explosive Growth
Gaxos.ai Inc. (GXAI) stock surged over 51% due to strong investor interest in its AI-driven growth. The company reported record Q2 2026 revenue of $2.46M, a 1,337% year-over-year increase, and achieved positive GAAP profitability after exiting its gaming division to focus on AI and …
Gaxos.ai Shares Jump in Premarket Trade; Asset Sale Gain Offsets Operating Loss
Gaxos.ai Inc. (NASDAQ:GXAI) shares surged 49.3% in premarket trading after reporting record quarterly revenue. Despite an operating loss accounting for 75.9% of sales, the company posted a net income attributable to the firm of $241,056, largely due to a $1.75 million profit from selling …
Xos, Inc. (XOS) CEO withholds 14,538 shares to cover RSU tax obligations
Xos, Inc. CEO Dakota Semler reported a Form 4 transaction where 14,538 shares of common stock were withheld by the company to satisfy tax obligations related to the vesting of Restricted Stock Unit (RSU) awards. The reference price for these shares was $2.70. After …
Xos, Inc. (XOS) COO Sordoni reports tax withholding of 13,663 shares
Xos, Inc. COO Giordano Sordoni reported a tax-related transaction where 13,663 shares of common stock were withheld by the issuer at $2.70 per share. This action was taken to satisfy tax withholding obligations stemming from the vesting of previously granted Restricted Stock Unit (RSU) …
Xos, Inc. (XOS) CFO withholds 3,163 shares to cover RSU tax liability
Xos, Inc.'s Chief Financial Officer, Liana Pogosyan, reported a disposition of 3,163 common shares on August 10, 2026, to cover tax liabilities associated with the vesting of Restricted Stock Unit (RSU) awards. The shares were valued at $2.70 each. Following this transaction, Pogosyan directly …
Gaxos Delivers Record Second-Quarter Revenue, Up 35.8% Sequentially and 1,337% Year over Year
Gaxos.ai Inc. reported record second-quarter consolidated revenue of $2.46 million, marking a 35.8% sequential increase and a 1,337% year-over-year increase. The company highlighted improved marketing efficiency, with revenue growth significantly outpacing advertising expense growth and revenue generated per advertising dollar improving by approximately 20%. …
Gaxos.AI Inc. (GXAI) pivots to AI health, logs Q2 profit and strong cash
Gaxos.AI Inc. (GXAI) reported a significant strategic pivot towards AI health and other AI applications, resulting in a Q2 2026 net income of $241,056, a substantial improvement from a loss in the prior year. The company's revenue surged to $2.46 million from $170,971 year-over-year, …
Wasatch Advisors LP Trims Holdings in Axos Financial, Inc $AX
Wasatch Advisors LP reduced its stake in Axos Financial (NYSE:AX) by 16.4% in the second quarter, selling over 100,000 shares but retaining a significant holding. Despite this reduction, institutional investors collectively own a large portion of the company, and analysts maintain a positive outlook …
Gaxos.ai shareholders approve equity plan amendment and reverse stock split authority
Gaxos.ai shareholders have approved an amendment to the company's 2022 Omnibus Equity Incentive Plan, increasing the number of common shares reserved for issuance. They also elected all four nominees to the board of directors and ratified Salberg & Company, P.A. as their independent public …
Form 8K GaxosAI Inc For: 11 August By Investing.com
This article reports that GaxosAI Inc. filed a Form 8K on August 11. It includes the company's stock symbol, GXAI, and its current percentage change in stock value. The content primarily serves as a placeholder or brief announcement for the SEC filing.
GSK plc (GSK) president reports acquisition of notional ADS in savings plan
GSK plc reported that its President, Maya Martinez-Davis, acquired 9.016 notional American Depositary Shares (ADS) at $52.9600 per ADS on August 7, 2026. This transaction occurred on the New York Stock Exchange and was part of her GSK Executive Supplemental Savings Plan account. The …
GSK Plc (GSK) Stock Analysis: Exploring A 9.66% Potential Upside In The Healthcare Giant
GSK Plc (GSK) shows a potential upside of 9.66% with a market capitalization of $106.07 billion and a forward P/E of 10.31, suggesting potential undervaluation. The company exhibits strong financial health with 5.30% revenue growth, a 33.38% ROE, and a 3.43% dividend yield. Analysts …
Price to sales forward of Gaxos.ai Inc. – NASDAQ:GXAI
This article provides financial information for Gaxos.ai Inc. under the NASDAQ:GXAI ticker. It specifically highlights the "Price to sales forward" metric for the company. The page appears to be a financial data portal, offering an overview of the company's financials, news, community, technicals, forecasts, …